Running hot in customers' hands: existing deployments are being used harder than they were sized for
The model's full reasoning — Q2 2022 call → NOWe need to determine if management describes that the company's product/service is being used more intensively by existing customers than originally expected, with this heavier usage observable in current business. Key points from transcript: - Revenue growth driven by procedure volumes and higher ASPs. - Active surgeon base increased 37% year-over-year to 2047, reaching 20% penetration of estimated 10,000 surgeons. - Surgeon utilization increased to 10.1 kits per surgeon from 9.8 a year ago. - Blended ASP increased 5% due to adoption of newer products. - Direct sales force expansion, but that's about channel. - No explicit statement about existing customers using more than expected. The utilization increase is modest (9.8 to 10.1). That's a small increase. Also, the growth is largely from adding new surgeons (37% increase in active surgeons) and new products. The transcript does not describe a phenomenon where existing customers are consuming more than planned. It mentions "surgeon utilization gains" but that's a general expectation. The increase from 9.8 to 10.1 is not described as "ahead of expectations" or "running hot". It's just a slight uptick. Also, the company talks about adding new surgeons and expanding direct sales force. The growth is more about new customers and new products. No mention of existing customers exhausting supplies faster or outgrowing capacity. The question asks if management describes that the product is being used more intensively than originally sized. There is no such statement. The utilization increase is modest and not framed as exceeding expectations. Also, the company mentions "steady gains" but not that it's ahead of plan. So answer NO. Thus, answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| APYX | Apyx Medical Corporation | Q4 2023 | 2024-03-21 | C |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| TJX | The TJX Companies, Inc. | Q2 2021 | 2021-08-18 | C |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| CCOI | Cogent Communications Holdings, Inc. | Q2 2017 | 2017-08-03 | B |
| GEO | The GEO Group, Inc. | Q2 2016 | 2016-08-02 | B+ |
TJX · Q2 2021 → YESThe question is about whether management describes that the company's product, service, capacity, or offering — already deployed with existing customers — is being used more intensively than originall...
WES · Q3 2018 → YESThe question is about whether management describes that the company's product, service, capacity, or offering — already deployed with existing customers — is being used more intensively than originall...
BCE · Q2 2017 → YESThe question is about whether management describes that the company's product, service, capacity, or offering — already deployed with existing customers — is being used more intensively than originall...